Markets:

Overview

News

Currencies

International

Treasuries

argenx SE - American Depositary Shares (NQ:ARGX)

821.96 -11.58 (-1.39%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about argenx SE - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Does ARGENX SE - ADR (NASDAQ:ARGX) meet the Minervini criteria? ↗

April 26, 2025

A fundamental and technical analysis of (NASDAQ:ARGX): Is ARGENX SE - ADR (NASDAQ:ARGX) suited for high growth investing?

Via Chartmill

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today ↗

April 21, 2025

Via Benzinga

What's Driving the Market Sentiment Around argenx? ↗

April 21, 2025

Via Benzinga

Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years ↗

April 18, 2025

Via Benzinga

FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting ↗

April 11, 2025

FDA approves Argenx's Vyvgart Hytrulo prefilled syringe for self-injection in gMG and CIDP, offering flexible dosing and expanding treatment options.

Via Benzinga

Argenx Bounds Off 200-Day Line On 'Best-Case Scenario' For Blockbuster Drug ↗

April 11, 2025

The prefilled syringe will cost 4% more than the under-the-skin shot.

Via Investor's Business Daily

P/E Ratio Insights for argenx ↗

March 20, 2025

Via Benzinga

What Analysts Are Saying About argenx Stock ↗

March 04, 2025

Via Benzinga

What 11 Analyst Ratings Have To Say About argenx ↗

April 11, 2025

Via Benzinga

Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket ↗

April 11, 2025

Via Benzinga

Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline ↗

April 09, 2025

Trump hints at major tariffs on foreign pharmaceuticals, sparking concerns for Indian suppliers and potential hikes in U.S. drug costs.

Via Benzinga

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today ↗

March 04, 2025

Via Benzinga

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today ↗

February 19, 2025

Via Benzinga

Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years ↗

January 30, 2025

Via Benzinga

Argenx's Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients ↗

April 08, 2025

Argenx reports long-term Vyvgart data showing lasting efficacy in gMG and CIDP, with strong safety and symptom control across multiple studies.

Via Benzinga

Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years ↗

March 31, 2025

Via Benzinga

Looking Into argenx's Recent Short Interest ↗

March 26, 2025

Via Benzinga

Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity ↗

March 04, 2025

Analysts remains bullish on the company's chances in depression and epilepsy. But investors aren't convinced.

Via Investor's Business Daily

Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years ↗

January 16, 2025

Via Benzinga

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts. ↗

January 09, 2025

Biotech stocks have seen three years of sideways to down trading. But obesity drugs, AI and Trump 2.0 promise to shake things up.

Via Investor's Business Daily

Topics Artificial Intelligence Government

Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years ↗

January 03, 2025

Via Benzinga

$1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today ↗

December 18, 2024

Via Benzinga

Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved with BHV-1300, Gains Analyst Approval ↗

December 17, 2024

Biohaven's BHV-1300 shows >60% IgG reduction in early trials with promising safety data, advancing its MoDE platform and regulatory milestones.

Via Benzinga

Looking Into argenx's Recent Short Interest ↗

December 09, 2024

Via Benzinga

(ARGX) - Analyzing argenx's Short Interest ↗

November 14, 2024

Via Benzinga

This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

November 12, 2024

Via Benzinga

Peering Into argenx's Recent Short Interest ↗

November 06, 2024

Via Benzinga

This eBay Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

November 05, 2024

Via Benzinga

Argenx Q3 Revenue, EPS Beats Excite Bullish Biotech Analysts: 'Most Enviable I&I Pipeline In Entire Industry' ↗

November 01, 2024

Argenx SE ADR shares jumped after impressive earnings. Analysts raised price targets and noted strong pipeline and global expansion.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

argenx SE - American Depositary Shares (NQ:ARGX)

Headline News about argenx SE - American Depositary Shares

Starting at $3.75/week.

Subscribe Today